Metabolic stress activates an ERK/hnRNPK/DDX3X pathway in pancreatic β cells

Austin L Good1, Matthew W Haemmerle1, Alexis U Oguh1

  • 1Institute for Diabetes, Obesity, and Metabolism and the Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.

Molecular Metabolism
|June 11, 2019
PubMed
Abstract

Insights

Researchers uncovered a new pathway involving ERK, hnRNPK, and DDX3X that impacts pancreatic beta cell survival during type 2 diabetes (T2D) stress.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Endocrinology

Background:

  • Pancreatic beta cell failure is central to type 2 diabetes (T2D) pathogenesis.
  • Post-transcriptional regulation of beta cell gene expression during stress is poorly understood.
  • JUND, a pro-oxidant transcription factor, is upregulated in beta cells under metabolic stress.

Purpose of the Study:

  • To elucidate the mechanisms controlling JUND's post-transcriptional upregulation in beta cells during metabolic stress.
  • To identify key regulatory proteins and signaling pathways involved in this maladaptive response.

Main Methods:

  • RNA immunoprecipitation and co-immunoprecipitation to study RNA-protein and protein-protein interactions.
  • Phos-tag analysis to assess hnRNPK phosphorylation.
  • Translating ribosome affinity purification (TRAP) to analyze mRNA ribosome occupancy.
  • CRISPR-Cas9 gene depletion and apoptosis assays in mouse and human islets and cell lines.

Main Results:

  • A poly-cytosine motif in JUND mRNA was identified, with hnRNPK binding to it.
  • hnRNPK loss prevented JUND upregulation during metabolic stress.
  • The MEK/ERK pathway phosphorylated hnRNPK, increasing JUND levels and pro-oxidant/inflammatory gene expression.
  • DDX3X was identified as an hnRNPK binding partner essential for JUND translation.

Conclusions:

  • A novel ERK/hnRNPK/DDX3X signaling pathway regulates beta cell survival.
  • This pathway is activated under conditions associated with type 2 diabetes.
  • Understanding this pathway offers potential therapeutic targets for T2D.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.6K
What is Metabolism?00:52

What is Metabolism?

Overview
131.4K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
48.9K
Responses to Heat and Cold Stress02:45

Responses to Heat and Cold Stress

Every organism has an optimum temperature range within which healthy growth and physiological functioning can occur. At the ends of this range, there will be a minimum and maximum temperature that interrupt biological processes.
14.7K
Responses to Salt Stress02:02

Responses to Salt Stress

Salt stress—which can be triggered by high salt concentrations in a plant’s environment—can significantly affect plant growth and crop production by influencing photosynthesis and the absorption of water and nutrients.
14.5K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
220